NeoStem, Inc’s (NBS) Video Details Promise of Current Adult Stem Cell Clinical Trials Targeting Widespread Diseases
NeoStem, Inc. (NBS), a leading-edge healthcare company that intends to capitalize on existing stem cell applications, has released an investor video detailing the promise of adult stem cells. Currently, clinical trials are underway to treat many of the world's most intractable diseases through stem cell therapy. In fact, this industry is so prevalent that analysts predict that the adult stem cell industry will generate approximately $8.5 billion in revenue by 2016. Robin Smith, MD, MBA, Chief Executive Officer of NeoStem, also details why the Company's services should play a key role as the field of Regenerative Medicine fulfills the promise…